Retin-A
Payments companies reported to CMS as associated with Retin-A. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Retin-A, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Retin-A
These are the largest totals companies reported as associated with Retin-A. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Yeh | Atlanta, GA | Ophthalmology | $88.96 |
| Bertha Baum | Hallandale Beach, FL | Dermatology | $57.19 |
| John Humeniuk | Greer, SC | Procedural Dermatology | $57.19 |
| Harold Farber | Philadelphia, PA | Dermatology | $47.05 |
| Mamina Turegano | Baton Rouge, LA | Dermatology | $47.05 |
Prescribed Retin-A?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.